[Re-resection for recurrent intrahepatic cholangiocarcinoma]

Sae Murakami1, Tetsuo Ajiki, Taro Okazaki

  • 1Dept. of Surgery, Division of Hepato-Biliary-Pancreatic Surgery, Kobe University Graduate School of Medicine.

Summary

For recurrent intrahepatic cholangiocarcinoma (IHC), re-resection or chemotherapy significantly improves survival compared to best supportive care. Re-resection is particularly effective for intrahepatic-only recurrence, offering prolonged survival benefits.

Related Concept Videos